These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32321330)

  • 1. Current radiotherapy techniques in NSCLC: challenges and potential solutions.
    Giaj-Levra N; Borghetti P; Bruni A; Ciammella P; Cuccia F; Fozza A; Franceschini D; Scotti V; Vagge S; Alongi F
    Expert Rev Anticancer Ther; 2020 May; 20(5):387-402. PubMed ID: 32321330
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
    Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
    Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
    Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
    J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for early stage lung cancer-historical developments and future strategies.
    Chua KLM; Sin I; Fong KW; Chua MLK; Onishi H
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S20. PubMed ID: 28917258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
    Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
    Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do radiation oncologists require for future advancements in lung SBRT?
    Ricardi U; Badellino S; Filippi AR
    Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer.
    Nakagawa T; Negoro Y; Matsuoka T; Okumura N; Dodo Y
    Respir Investig; 2014 Jul; 52(4):221-6. PubMed ID: 24998368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
    Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
    Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
    Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage I Lung SBRT Clinical Practice Patterns.
    Corso CD; Park HS; Moreno AC; Kim AW; Yu JB; Husain ZA; Decker RH
    Am J Clin Oncol; 2017 Aug; 40(4):358-361. PubMed ID: 25503436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer.
    Kishan AU; Lee P
    Semin Respir Crit Care Med; 2016 Oct; 37(5):716-726. PubMed ID: 27732993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.